Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TransMedics (TMDX) Change in Cash (2018 - 2025)

TransMedics (TMDX) has 8 years of Change in Cash data on record, last reported at $22.2 million in Q4 2025.

  • For Q4 2025, Change in Cash rose 238.5% year-over-year to $22.2 million; the TTM value through Dec 2025 reached $151.7 million, up 360.85%, while the annual FY2025 figure was $151.7 million, 360.85% up from the prior year.
  • Change in Cash reached $22.2 million in Q4 2025 per TMDX's latest filing, down from $65.6 million in the prior quarter.
  • Across five years, Change in Cash topped out at $386.8 million in Q2 2023 and bottomed at -$155.4 million in Q3 2023.
  • Average Change in Cash over 5 years is $23.2 million, with a median of $366500.0 recorded in 2021.
  • Peak YoY movement for Change in Cash: soared 6275.1% in 2022, then plummeted 884.7% in 2023.
  • A 5-year view of Change in Cash shows it stood at $3.1 million in 2021, then plummeted by 206.32% to -$3.3 million in 2022, then tumbled by 884.7% to -$32.3 million in 2023, then surged by 120.3% to $6.6 million in 2024, then surged by 238.5% to $22.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Cash were $22.2 million in Q4 2025, $65.6 million in Q3 2025, and $90.4 million in Q2 2025.